4.7 Article

Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Surgical Quality, Antihypertensive Therapy, and Electrolyte Balance: A Novel Trifecta to Assess Long-Term Outcomes of Adrenal Surgery for Unilateral Primary Aldosteronism

Umberto Anceschi et al.

Summary: A study proposed a trifecta as a predictor for postoperative endpoints and their maintenance after adrenalectomy in patients with unilateral primary aldosteronism. The trifecta includes changes in antihypertensive therapeutic intensity score, absence of hypokalemia, and absence of Clavien grade 2-5 complications. The study found that the trifecta and adenoma size are independent predictors of long-term success in clinical, biochemical, or combined aspects after adrenalectomy for unilateral primary aldosteronism.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medical Laboratory Technology

Aldosterone suppresses cardiac mitochondria

Chi-Sheng Hung et al.

Summary: Aldosterone suppresses cardiac mitochondria through MR-ROS signaling pathway in vivo and directly.

TRANSLATIONAL RESEARCH (2022)

Article Medicine, General & Internal

Minimally Invasive Partial vs. Total Adrenalectomy for the Treatment of Unilateral Primary Aldosteronism: A Systematic Review and Meta-Analysis

Rocco Simone Flammia et al.

Summary: This study systematically reviewed and meta-analyzed the differences in perioperative and functional outcomes between mi-PA and mi-TA for uPHA. The results showed that mi-PA and mi-TA provided comparable perioperative and functional outcomes in uPHA patients. However, the limited use of standardized reporting criteria in the included studies leaves the question of superiority of mi-PA over mi-TA in the treatment of uPHA open.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Peripheral Vascular Disease

Left ventricular remodeling and dysfunction in primary aldosteronism

Cheng-Hsuan Tsai et al.

Summary: Primary aldosteronism (PA) is a common cause of secondary hypertension and is associated with worse cardiovascular outcomes. Studies have shown that patients with PA have more severe LV remodeling, which may lead to cardiac dysfunction and other complications.

JOURNAL OF HUMAN HYPERTENSION (2021)

Review Biochemistry & Molecular Biology

Inflammatory Mechanisms Contributing to Endothelial Dysfunction

Panagiotis Theofilis et al.

Summary: Maintenance of endothelial cell integrity is crucial for human health, as dysfunction can lead to various diseases. Activated and injured endothelial cells release inflammatory mediators and enter a pro-thrombotic state, ultimately promoting atherosclerosis progression. Various pathways and mechanisms contribute to endothelial dysfunction, highlighting the complexity of this process.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Endothelial Dysfunction in Primary Aldosteronism

Zheng-Wei Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Cardiac & Cardiovascular Systems

IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis

Chia-Hung Chou et al.

CARDIOVASCULAR RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Essential role of ICAM-1 in aldosterone-induced atherosclerosis

Vincenzo Marzolla et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Endocrinology & Metabolism

Mineralocorticoid receptor null mice: informing cell-type-specific roles

Timothy J. Cole et al.

JOURNAL OF ENDOCRINOLOGY (2017)

Review Cardiac & Cardiovascular Systems

Mitochondrial DNA mutations and cardiovascular disease

Alexander W. Bray et al.

CURRENT OPINION IN CARDIOLOGY (2017)

Review Medicine, General & Internal

Primary Aldosteronism: Diagnosis and Management

Geeta Gyamlani et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)

Article Hematology

Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors

Dafina Pruthi et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)

Review Endocrinology & Metabolism

Mitochondrial DNA damage and atherosclerosis

Emma P. K. Yu et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)

Review Cardiac & Cardiovascular Systems

Mitochondria and Endothelial Function

Matthew A. Kluge et al.

CIRCULATION RESEARCH (2013)

Review Medicine, Research & Experimental

Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte

Laura A. Bienvenu et al.

CLINICAL SCIENCE (2013)

Article Cardiac & Cardiovascular Systems

Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity

Nicola Schaefer et al.

EUROPEAN HEART JOURNAL (2013)

Review Hematology

Vascular endothelial-cadherin and vascular stability

Elisabetta Dejana et al.

CURRENT OPINION IN HEMATOLOGY (2012)

Review Biochemistry & Molecular Biology

Regulation of Endothelial Function by Mitochondrial Reactive Oxygen Species

Michael E. Widlansky et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Biochemistry & Molecular Biology

Mitochondrial biogenesis and the development of diabetic retinopathy

Julia M. Santos et al.

FREE RADICAL BIOLOGY AND MEDICINE (2011)

Article Cell Biology

C5a promotes migration, proliferation, and vessel formation in endothelial cells

Ryuji Kurihara et al.

INFLAMMATION RESEARCH (2010)

Article Peripheral Vascular Disease

Endogenous endothelial cell signaling systems maintain vascular stability

Nyall R. London et al.

ANGIOGENESIS (2009)

Review Cardiac & Cardiovascular Systems

Mitochondrial dysfunction in atherosclerosis

Nageswara R. Madamanchi et al.

CIRCULATION RESEARCH (2007)

Article Biochemistry & Molecular Biology

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

Jane A. Leopold et al.

NATURE MEDICINE (2007)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in cardiovascular disease

SW Ballinger

FREE RADICAL BIOLOGY AND MEDICINE (2005)